BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14579284)

  • 1. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
    Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
    Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle regulation during mouse olfactory neurogenesis.
    Legrier ME; Ducray A; Propper A; Chao M; Kastner A
    Cell Growth Differ; 2001 Dec; 12(12):591-601. PubMed ID: 11751454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors.
    Jackson SK; DeLoose A; Gilbert KM
    Immunology; 2002 Aug; 106(4):486-95. PubMed ID: 12153511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
    Jackson SK; DeLoose A; Gilbert KM
    J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
    Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
    Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
    Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
    Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
    Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin-dependent kinase inhibitors in taste buds of mouse and hamster.
    Hirota M; Ito T; Okudela K; Kawabe R; Hayashi H; Yazawa T; Fujita K; Kitamura H
    Tissue Cell; 2001 Feb; 33(1):25-32. PubMed ID: 11292167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
    Li L; Iwamoto Y; Berezovskaya A; Boussiotis VA
    Nat Immunol; 2006 Nov; 7(11):1157-65. PubMed ID: 17013388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
    Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
    Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
    Kubsch S; Graulich E; Knop J; Steinbrink K
    Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes.
    Boussiotis VA; Freeman GJ; Taylor PA; Berezovskaya A; Grass I; Blazar BR; Nadler LM
    Nat Med; 2000 Mar; 6(3):290-7. PubMed ID: 10700231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
    Powell JD; Lerner CG; Schwartz RH
    J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
    Fouty BW; Rodman DM
    Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors.
    Corroyer S; Schittny JC; Djonov V; Burri PH; Clement A
    Pediatr Res; 2002 Feb; 51(2):169-76. PubMed ID: 11809910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
    Geisen C; Karsunky H; Yücel R; Möröy T
    Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
    Kriegel MA; Adam-Klages S; Gabler C; Blank N; Schiller M; Scheidig C; Kalden JR; Lorenz HM
    Int Immunol; 2008 Apr; 20(4):601-13. PubMed ID: 18310062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.